agilon health (AGL) Shares Skyrocket, What You Need To KnowShares of healthcare services company Agilon Health (
NYSE:AGL) jumped 16.4% in the morning session after the company reported decent third-quarter results that beat revenue expectations but fell significantly short on profitability.
AGL Q3 Deep Dive: Revenue Beats Expectations Amid Profitability Challenges and Strategic RealignmentHealthcare services company Agilon Health (
NYSE:AGL) announced better-than-expected revenue in Q3 CY2025, but sales fell by 1.1% year on year to $1.44 billion. The company expects the full year’s revenue to be around $5.82 billion, close to analysts’ estimates. Its GAAP loss of $0.27 per share was 60% below analysts’ consensus estimates.
agilon health’s (NYSE:AGL) Q3 Sales Top EstimatesHealthcare services company Agilon Health (
NYSE:AGL) reported Q3 CY2025 results topping the market’s revenue expectations, but sales fell by 1.1% year on year to $1.44 billion. The company expects the full year’s revenue to be around $5.82 billion, close to analysts’ estimates. Its GAAP loss of $0.27 per share was 62.4% below analysts’ consensus estimates.
agilon health Reports Third Quarter 2025 Results and Re-Establishes Full Year Outlook
agilon health, inc. (
NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2025 and provided a full-year 2025 outlook.
What To Expect From agilon health’s (AGL) Q3 EarningsHealthcare services company Agilon Health (
NYSE:AGL) will be reporting results this Tuesday after the bell. Here’s what to look for.
Halper Sadeh LLC Encourages agilon health, inc. Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of agilon health, inc. (
NYSE: AGL) breached their fiduciary duties to shareholders.
Rosen Law Firm Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation – AGL
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (
NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.
Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To KnowA number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.
3 Unprofitable Stocks We Find RiskyRunning at a loss can be a red flag.
Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.
Rosen Law Firm Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation – AGL
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (
NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.
agilon health Sets Date to Report Third Quarter 2025 Financial Results
agilon health, inc. (
NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the third quarter 2025 after market close on Tuesday, November 4, 2025 and host a conference call at 4:30 p.m. ET to discuss the results.
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To KnowA number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations.
AGILON INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Encourages Investors in Agilon Health, Inc. to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options
AGILON HEALTH INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of agilon health, inc. - AGL
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has continued its investigation into agilon health, inc. (“agilon” or the “Company”) (
NYSE: AGL).
agilon health (AGL): Buy, Sell, or Hold Post Q2 Earnings?Shareholders of agilon health would probably like to forget the past six months even happened. The stock dropped 75.4% and now trades at $1.11. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Unpacking Q2 Earnings: agilon health (NYSE:AGL) In The Context Of Other Outpatient & Specialty Care StocksAs the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the outpatient & specialty care industry, including agilon health (
NYSE:AGL) and its peers.
AGILON HEALTH INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of agilon health, inc. – AGLNEW YORK and NEW ORLEANS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has continued its investigation into agilon health, inc. (“agilon” or the “Company”) (
NYSE: AGL).
agilon health to Participate in the 2025 Jefferies Healthcare Services Conference
agilon health, inc. (
NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team will participate in a fireside chat at the 2025 Jefferies Healthcare Services Conference on Tuesday, September 30 at 8:45am ET.
